Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Ibrahim Al Sulaihim"'
Autor:
Khalid Al Sulaiman BCCCP, BCNSP, MBA, FCCM, Ohoud Aljuhani Pharm.D, BCCCP, Ghazwa B. Korayem Pharm.D, Ali F. Altebainawi Pharm.D, Ramesh Vishwakarma PhD, Mashael AlFaifi Pharm.D, Samiah Alsohimi Pharm.D, Aljoharah Alrayes Pharm.D, Sara Albishi Pharm.D, Reem Alqahtani Pharm.D, Mai Alalawi Pharm.D, Ibrahim Al Sulaihim MSc, Thamer A. Alanazi BSc, Rahaf A. Alqahtani Pharm.D, Alaa Almagthali Pharm.D, Shahamah Jomah BSc, Areej Alshlowi BSc, Tahani R. Alshammari BSc, Shahad S. Alzahrani Pharm.D, Marwa I. Abdulqader Pharm.D
Publikováno v:
Clinical and Applied Thrombosis/Hemostasis, Vol 29 (2023)
The use of erythropoietin-stimulating agents (ESAs) as adjunctive therapy in critically ill patients with COVID-19 may have a potential benefit. This study aims to evaluate the effect of ESAs on the clinical outcomes of critically ill COVID-19 patien
Externí odkaz:
https://doaj.org/article/ab9da515360c473da3833245deda4fd1
Autor:
Khalid Al Sulaiman, Ohoud Aljuhani, Hisham A. Badreldin, Ghazwa B. Korayem, Abeer A. Alenazi, Ahlam H. Alharbi, Albandari Alghamdi, Alaa Alhubaishi, Ali F. Altebainawi, Mohammad Bosaeed, Rand Alotaibi, Ahad Alawad, Nirvana Alnajjar, Khalid Bin Saleh, Walaa A. Sait, Samiah Alsohimi, Meshari M. Alanizy, Sarah A. Almuqbil, Ibrahim Al Sulaihim, Ramesh Vishwakarma, Mai Alalawi, Fatimah Alhassan, Suliman Alghnam
Publikováno v:
BMC Infectious Diseases, Vol 23, Iss 1, Pp 1-8 (2023)
Abstract Background Previous studies have shown that non-critically ill COVID-19 patients co-infected with other respiratory viruses have poor clinical outcomes. However, limited studies focused on this co-infections in critically ill patients. This
Externí odkaz:
https://doaj.org/article/04c83215625a45baa6163d5fb8f70490
Autor:
Khalid Al Sulaiman, Ohoud Aljuhani, Abdullah M. Alhammad, Kholoud Al Aamer, Sara Alshehri, Abdulmohsen Alhuwahmel, Abdullah Kharbosh, Areej Alshehri, Hanan Alshareef, Ibrahim Al Sulaihim, Albandari Alghamdi, Shmeylan Al Harbi, Ramesh Vishwakarma, Numan Alabdan, Yousef Alrajhi, Abdulmalik Al Katheri, Abeer A. Alenazi, Mai Alalawi, Ghassan Al Ghamdi
Publikováno v:
Saudi Pharmaceutical Journal, Vol 30, Iss 12, Pp 1748-1754 (2022)
Background: Colistin is considered a valuable and last-resort therapeutic option for MDR gram-negative bacteria. Nephrotoxicity is the most clinically pertinent adverse effect of colistin. Vivo studies suggest that administering oxidative stress-redu
Externí odkaz:
https://doaj.org/article/141586f1e6774c669d035172211621cb
Autor:
Khalid Al Sulaiman, Ohoud Aljuhani, Hisham A. Badreldin, Ghazwa B. Korayem, Abeer A. Alenazi, Ahlam H. Alharbi, Albandari Alghamdi, Alaa Alhubaishi, Ali F. Altebainawi, Mohammad Bosaeed, Rand Alotaibi, Ahad Alawad, Nirvana Alnajjar, Khalid Bin Saleh, Walaa A. Sait, Samiah Alsohimi, Meshari M. Alanizy, Sarah A. Almuqbil, Ibrahim Al Sulaihim, Ramesh Vishwakarma, Mai Alalawi, Fatimah Alhassan, Suliman Alghnam
Publikováno v:
BMC Infectious Diseases, Vol 23, Iss 1, Pp 1-2 (2023)
Externí odkaz:
https://doaj.org/article/17a9efe44ca446ddb46c7f3af835b0e6
Autor:
Khalid Al Sulaiman, Ohoud Aljuhani, Ghazwa B. Korayem, Ali F. Altebainawi, Shmeylan Al Harbi, Abdulrahman Al Shaya, Hisham A. Badreldin, Raed Kensara, Abdullah F. Alharthi, Jahad Alghamdi, Ahad Alawad, Rand Alotaibi, Abdullah Kharbosh, Hessa Al Muqati, Abdulmohsen Alhuwahmel, Mohammed Almusallam, Ghada Albarrak, Ibrahim Al Sulaihim, Bader Alanazi, Bodoor S. Al-Dosari, Ramesh Vishwakarma, Alawi S. Alsaeedi, Ghassan Al Ghamdi, Hadeel Alkofide, Hasan M. Al-Dorzi
Publikováno v:
Frontiers in Public Health, Vol 10 (2022)
BackgroundThe cardiovascular complications of Coronavirus Disease 2019 (COVID-19) may be attributed to the hyperinflammatory state leading to increased mortality in patients with COVID-19. HMG-CoA Reductase Inhibitors (statins) are known to have plei
Externí odkaz:
https://doaj.org/article/497e868d0a4c41eabcb9464903f68d69
Autor:
Khalid Al Sulaiman, Ohoud Al Juhani, Abdullah Alhammad, Kholoud Al Aamer, Sara Alshehri, Abdulmohsen Alhuwahmel, Abdullah Kharbosh, Areej Alshehri, Hanan Al Shareef, Ibrahim Al Sulaihim, Albandari Alghamdi, Shmeylan Al Harbi, Numan Abdan, Abdulmalik Al Katheri, Yousef Alrajhi, Ramesh Vishwakarma
BackgroundColistin antibiotic is considered a valuable and last-resort therapeutic option for MDR gram-negative bacteria. Nephrotoxicity is the most clinically pertinent adverse effect for colistin. Vivo studies suggest that administering oxidative s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8a229c1bf1f4c64d42d71e331aa7ac9e
https://doi.org/10.21203/rs.3.rs-1254017/v1
https://doi.org/10.21203/rs.3.rs-1254017/v1
Autor:
Khalid Al Sulaiman, Ohoud Aljuhani, Ghazwa B. Korayem, Ali F. Altebainawi, Shmeylan Al Harbi, Abdulrahman Al Shaya, Hisham A. Badreldin, Raed Kensara, Abdullah Al Harthi, Jahad Alghamdi, Ahad Alawad, Rand Alotaibi, Abdullah Kharbosh, Hessa Al Muqati, Abdulmohsen Alhuwahmel, Mohammed Almusallam, Ghada Albarrak, Ibrahim Al Sulaihim, Bader Alanazi, Bodoor S. Al-Dosari, Ramesh Vishwakarma, Alawi S. Alsaeedi, Ghassan Al Ghamdi, Hasan M Al-Dorzi
Background The cardiovascular complications of Severe Coronavirus Disease 2019 (COVID-19) may be attributed to the hyperinflammatory state leading to increased mortality in patients with COVID-19. Statins are known to have pleiotropic and anti-inflam
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::95aa4aafaf963ac55c2e8fa22f624d44
https://doi.org/10.21203/rs.3.rs-828175/v3
https://doi.org/10.21203/rs.3.rs-828175/v3
Autor:
Abdulrahman Al Shaya, Abdullah Al Harthi, Ohoud Aljuhani, Bodoor S. Al-Dosari, Ramesh Vishwakarma, Abdulmohsen Alhuwahmel, Ghazwa B. Korayem, Jahad Alghamdi, Hisham A. Badreldin, Bader Alanazi, Khalid Al Sulaiman, Ghassan Al Ghamdi, Ibrahim Al Sulaihim, Hasan M. Al-Dorzi, Ali F. Altebainawi, Mohammed Almusallam, Hessa Al Muqati, Rand Alotaibi, Shmeylan Al Harbi, Alawi S. Alsaeedi, Ahad Alawad, Raed Kensara, Abdullah Kharbosh
Purpose The complications of Severe Corona Virus Disease 2019 (COVID-19) are attributed to the overproduction of early response proinflammatory cytokines, causing a systemic hyperinflammatory state. Statins are potentially a potent adjuvant therapy i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dc9bf8cfdd74f2185bc0cc97bb860231
https://doi.org/10.21203/rs.3.rs-828175/v2
https://doi.org/10.21203/rs.3.rs-828175/v2